Dr Ravi Assomull is a Consultant Cardiologist with specialist interests in advanced cardiovascular imaging and coronary intervention. Other clinical interests include heart muscle disease and sports cardiology.
Consultant Cardiologist and Clinical Lead for Community Cardiology at Imperial College NHS Trust service (Ealing service).
Consultant Interventional Cardiologist and Director of Cardiac MRI at London Northwest Healthcare NHS Trust.
Dr Ravi Assomull is an experienced cardiologist having been appointed to his consultant post in 2012. He was recruited to Ealing Hospital by the team led by Professor Jaspal Kooner specifically to set up a cardiac magnetic resonance (CMR) service. He established the service which was a unique undertaking at that time being one of the only CMR units in a district general hospital. He also specialises in coronary intervention performing coronary angiography and stent implantation. His specialist training in advanced cardiac imaging during his research period enhances his interventional practice by guiding and refining the interventional procedures he undertakes. By using these complementary skills, he ensures his patients only receive invasive therapy when there is robust evidence that they will benefit from it.
He enjoys the range of clinical challenges in cardiology and embraces the rapid progress in this specialty. Specifically, he has an interest in using wearable technology to help patients care better for themselves and to aid with conditions that are often difficult to diagnose. He screens professional footballers for cardiovascular disease and has developed a further interest in sports cardiology.
Dr Assomull has regular clinics across the week across a range of sites. He also performs coronary intervention at The Wellington Hospital in St John’s Wood.
Dr Assomull has teamed up with Dr Fakhar Khan and Dr Sayan (Shai) Sen to create the One Heart Clinic – a clinic which uses his own specialist skills along with those of his One Heart Clinic partners; Dr Khan is a specialist in cardiac rhythm disturbances and pacemaker implantations and Dr Sen is an interventional cardiologist who also undertakes cutting-edge Transcutaneous (keyhole) Aortic Valve Interventions (TAVI).
Education & Training
Dr Ravi Assomull undertook his medical training at The University of Cambridge having qualified in 1999. He was awarded a British Heart Foundation Junior Fellowship to fund his MD research degree in The Cardiac MRI unit at The Royal Brompton Hospital.
He has worked in some of the top teaching hospitals in London including Royal Brompton, Harefield, St George’s, The Heart as well as St Mary’s and Hammersmith.
His specialist Cardiology Training was in the North West London rotation where he was awarded the prestigious Imperial College Interventional Fellowship for 2 years in succession.
Dr Assomull is the training lead for Cardiology in North West London. He appraises current Cardiology trainees and is regularly called upon to interview junior doctors who wish to be part of the next generation of UK cardiologists.
More recently, he has been charged with upskilling local general practitioners in Ealing as well as Hammersmith & Fulham. Specifically, he has developed a training and mentorship program to allow GPs to acquire and interpret ECGs in their own surgeries allowing these patients to be potentially investigated and treated closer to home.
His British Heart Foundation-funded thesis in the applications of Cardiac MRI in heart failure resulted in multiple high-impact publications and has been practice-changing with respect to how patients with heart failure are risk-stratified for sudden cardiac death. This work resulted in the award of The Ralph Noble Prize for the academic year of 2012-2013 by the University of Cambridge.
As a consequence, his work has been presented at International Conferences in both Europe and the USA and continues to be widely cited in the medical literature. He is still involved in research exploring the applications of Cardiac MRI in heart muscle disease.
He continues to be actively involved in research and was a co-author in the ORBITA study published in 2017 in Lancet.